D-WAVE QUANTUM INC (QBTS)

US26740W1099 - Common Stock

7.6065  +1.17 (+18.11%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to QBTS. QBTS was compared to 280 industry peers in the Software industry. QBTS may be in some trouble as it scores bad on both profitability and health. QBTS is quite expensive at the moment. It does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

QBTS had negative earnings in the past year.
QBTS had a negative operating cash flow in the past year.

1.2 Ratios

Looking at the Return On Assets, with a value of -148.94%, QBTS is doing worse than 93.55% of the companies in the same industry.
Industry RankSector Rank
ROA -148.94%
ROE N/A
ROIC N/A
ROA(3y)-142.44%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

QBTS has a Gross Margin (64.27%) which is in line with its industry peers.
QBTS's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for QBTS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.79%
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

QBTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for QBTS has been increased compared to 1 year ago.
Compared to 1 year ago, QBTS has a worse debt to assets ratio.

2.2 Solvency

QBTS has an Altman-Z score of -2.86. This is a bad value and indicates that QBTS is not financially healthy and even has some risk of bankruptcy.
QBTS's Altman-Z score of -2.86 is on the low side compared to the rest of the industry. QBTS is outperformed by 80.29% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.86
ROIC/WACCN/A
WACC10.65%

2.3 Liquidity

QBTS has a Current Ratio of 1.36. This is a normal value and indicates that QBTS is financially healthy and should not expect problems in meeting its short term obligations.
QBTS has a Current ratio (1.36) which is comparable to the rest of the industry.
QBTS has a Quick Ratio of 1.28. This is a normal value and indicates that QBTS is financially healthy and should not expect problems in meeting its short term obligations.
QBTS has a Quick ratio (1.28) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.28

6

3. Growth

3.1 Past

QBTS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.94%, which is quite impressive.
QBTS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.23%.
Measured over the past years, QBTS shows a quite strong growth in Revenue. The Revenue has been growing by 19.28% on average per year.
EPS 1Y (TTM)41.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.27%
Revenue 1Y (TTM)14.23%
Revenue growth 3Y19.28%
Revenue growth 5YN/A
Sales Q2Q%-27.01%

3.2 Future

Based on estimates for the next years, QBTS will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.55% on average per year.
Based on estimates for the next years, QBTS will show a very strong growth in Revenue. The Revenue will grow by 47.33% on average per year.
EPS Next Y48.67%
EPS Next 2Y23.07%
EPS Next 3Y18.77%
EPS Next 5Y15.55%
Revenue Next Year-15.16%
Revenue Next 2Y17.97%
Revenue Next 3Y46.44%
Revenue Next 5Y47.33%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

QBTS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QBTS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

QBTS's earnings are expected to grow with 18.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.07%
EPS Next 3Y18.77%

0

5. Dividend

5.1 Amount

QBTS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

D-WAVE QUANTUM INC

NYSE:QBTS (12/23/2024, 12:24:08 PM)

7.6065

+1.17 (+18.11%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-14 2024-11-14/bmo
Earnings (Next)N/A N/A
Inst Owners52.59%
Inst Owner Change3.58%
Ins Owners1.36%
Ins Owner Change-183.87%
Market Cap2.21B
Analysts81.67
Price Target3.01 (-60.43%)
Short Float %14.7%
Short Ratio0.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.16%
Min EPS beat(2)-0.88%
Max EPS beat(2)0.56%
EPS beat(4)2
Avg EPS beat(4)-5.31%
Min EPS beat(4)-26.05%
Max EPS beat(4)5.12%
EPS beat(8)3
Avg EPS beat(8)-14.59%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-26%
Min Revenue beat(2)-27.66%
Max Revenue beat(2)-24.33%
Revenue beat(4)0
Avg Revenue beat(4)-28.23%
Min Revenue beat(4)-39.75%
Max Revenue beat(4)-21.2%
Revenue beat(8)0
Avg Revenue beat(8)-23.4%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.67%
PT rev (3m)5.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.23%
EPS NY rev (1m)8.17%
EPS NY rev (3m)13.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-39.54%
Revenue NY rev (1m)-10.78%
Revenue NY rev (3m)-10.78%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 234.69
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0.03
BVpS-0.06
TBVpS-0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -148.94%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.27%
FCFM N/A
ROA(3y)-142.44%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.79%
GM growth 5YN/A
F-Score4
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 157.92%
Cap/Sales 17.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1.28
Altman-Z -2.86
F-Score4
WACC10.65%
ROIC/WACCN/A
Cap/Depr(3y)75.23%
Cap/Depr(5y)N/A
Cap/Sales(3y)15.34%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.27%
EPS Next Y48.67%
EPS Next 2Y23.07%
EPS Next 3Y18.77%
EPS Next 5Y15.55%
Revenue 1Y (TTM)14.23%
Revenue growth 3Y19.28%
Revenue growth 5YN/A
Sales Q2Q%-27.01%
Revenue Next Year-15.16%
Revenue Next 2Y17.97%
Revenue Next 3Y46.44%
Revenue Next 5Y47.33%
EBIT growth 1Y13.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1.65%
EBIT Next 3Y5.66%
EBIT Next 5Y13.71%
FCF growth 1Y13.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.06%
OCF growth 3YN/A
OCF growth 5YN/A